Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference
(Thomson Reuters ONE) -
DUBLIN, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc
(NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the
discovery, development and commercialization of novel protein immunotherapies,
today announced that members of its senior management team will present and
participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference on July
12(th) at 11:45 AM ET in New York, NY.
A live webcast of the company presentation can be accessed through the investor
relations section of the Company's website at www.prothena.com. Following the
live presentation, a replay of the webcast will be available on the Company's
website for at least 90 days following the presentation date.
About Prothena
Prothena Corporation plc is a global, late-stage clinical biotechnology company
seeking to fundamentally change the course of progressive diseases with its
clinical pipeline of novel therapeutic antibodies. Fueled by its deep scientific
understanding built over decades of research in protein misfolding and cell
adhesion - the root causes of many serious or currently untreatable amyloid and
inflammatory diseases - Prothena has advanced several drug candidates into
clinical trials while pursuing discovery of additional novel therapies. Our
pipeline of antibody-based product candidates targets a number of potential
indications including AL amyloidosis (NEOD001), Parkinson's disease and other
related synucleinopathies (PRX002) and inflammatory diseases, including
psoriasis (PRX003), and TTR amyloidosis (PRX004). For more information, please
visit the company's web site at www.prothena.com.
For more information, please visit the company's web site at www.prothena.com.
Contacts
Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Ellen Rose
650-922-2405, ellen.rose(at)prothena.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Prothena Corporation plc via GlobeNewswire
[HUG#2024632]
Unternehmensinformation / Kurzprofil:
Datum: 06.07.2016 - 22:05 Uhr
Sprache: Deutsch
News-ID 481947
Anzahl Zeichen: 2691
contact information:
Town:
DUBLIN
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 270 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prothena to Participate in Cantor Fitzgerald's 2nd Annual Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
